侵袭性肺曲霉菌病(invasive pulmonary aspergillosis,IPA)是曲霉菌侵入肺组织引起的深部真菌感染性疾病,主要发生在免疫低下人群。近年来,随着广谱抗生素、糖皮质激素、免疫抑制剂的长期应用,已有一些慢性病生存时间延长,各种导管介入性治疗和器官移植治疗的深入开展,侵袭性曲霉菌病的发病率不断 Invasive pulmonary aspergillosis (IPA) is a deep fungal infection caused by Aspergillus invades into the lung tissue, mainly in the immunocompromised population. In recent years, with the long-term application of broad-spectrum antibiotics, glucocorticoids and immunosuppressive agents, some chronic diseases have been prolonged survival time, a variety of catheter interventional therapy and organ transplantation treatment in depth, the incidence of invasive aspergillosis Constantly